Vision Mission & Strength
Quality Policy
Manufacturing Facility
R & D
Management Messages
Business Motto
Doxiva Montiva
Bexen Cefracef Fixpro Nixon Roxcef Roxcef injection Xinarox CV
Metavas MR Nitrogina SR
Tamino ER Tamino Plus
Vermikil
Florocin Revalon Toplevo 500
Azaltic
Diacana Diazid Empa Glucomin Lijenta 5 Lijenta-M
Receca
Anxionil Lyrinex Pandura Thixtra
AMX Halopen
Flurodent
Mesala
Altrip
Nitide
Adarbi Bisopress Losarva Lovapres 5
Mecliz Plus Prokinet
Defungi Symbiotrin
Meroxin
Esotor Gastab Omecron Pansos Rablet
Arcet Fexten Itchlor Rupatid
Visnil
Isosal
Broculyt Erdostin Mucodil Nacsol
Irobest
Oxydrop
Etrib Flexivan Flexivan ER Nimovo Nipoxen Toralin Vurdon SR
Niprolac Oral Sol
D-Star Nipro Gold Oxi-Q Polytamin Starcal Starcal D Starcal D Forte Starcal M V3N V4Z Vegecap-E
Avator Rovator
Reflexen
Cialix Danafil
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka. The conference was inaugurated by Mr. Md. Abdur Razzaq, founder Managing Director of JMI Group. He expressed his gratitude to the employees for outstanding performance they made this year too. Mr. Md. Mizanur Rahman, CEO of the company presented the performance of 2018 and provided the strategic marketing direction for 2019 to keep the phenomenal growth in the market. He also thanked to the clinicians for their continuous support in favor of the company. Mr. Jabed Iqbal Pathan, Chairman of the company praised the people for their relentless and quality effort for building the brand in the very competitive market. Other Directors, Foreign delegates, Managers along with 1400 marketing people across the country were present. In the conference, best performers in different categories were awarded duly.
Md. Mizanur Rahman, Chief Executive Officer (CEO) of NIPRO JMI Pharma Limited, has received a prestigious award as the best pharmaceutical professional in Bangladesh-2018.
Quality of the products is our inherent philosophy by which we serve the ailing humanity...
NIPRO JMI Pharma Ltd (NJP), a Japan Bangladesh Company, held their annual sales conference on 27th December, 2017 at Cox's Bazar, the city of longest sea beach of the World....
NIPRO JMI Pharma Ltd. celebrated Happy New Year 2018 - at corporate office...
Injection Meroxin (Meropenem) and Roxcef (Cefuroxime) have been launched today(11.12.2017) at Pan Pacific Sonargaon, Dhaka....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1424 (Pohela Boishakh) at Corporate office....
Md. Abdur Razzaq, Founder Managing Director of JMI Group achieved CIP (Industry) award for his outstanding and exceptional contribution to the large Industry (Manufacturing) of Bangladesh.....
NIPRO JMI Pharma, a Japan Bangladesh joint venture company, arranged Annual Sales Conference 2016 at International Convention Center, Bashundhara, Dhaka. Md. Abdur Razzaq, the Managing Director, inaugurated the program and expressed his gratitude to all employees for the incredible growth of the company....
SA TV Footage of NIPRO JMI Pharma Annual Sales Co...
Md. Abdur Razzaq, Managing director of JMI Group, ...
NIPRO JMI Pharma (NJP) Organized Annual Sales Conf...
